News
Neha Anand, Analyst, Biopharma Intelligence Services, Citeline, explains how the approval of Embrelis marks a pivotal moment ...
Gov. Glenn Youngkin says he has a deal for a multi-billion-dollar pharmaceutical factory in Virginia, but he doesn't have a ...
The UK is the first country to introduce a dedicated law to decentralise manufacturing of personalised medicines at the point ...
India's pharmaceutical industry boasts global stature as the 'Pharmacy of the World' but faces significant domestic challenges from informal credit systems. Here's why ...
Dutch citizens are willing to accept higher public spending on a medicine if it provides significant health benefits, a study has found.
President Ferdinand "Bongbong" Marcos Jr. on Wednesday confirmed that the Philippines will open several key markets to US ...
The company said the Virginia facility "would be AstraZeneca’s largest single manufacturing investment in the world." The ...
ADARx Pharmaceuticals CEO Zhen Li found her way to biopharma through Merck, where she was inspired by the application of ...
President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.
A functional precision medicine platform intends to streamline cancer treatment by matching patients against a battery of FDA ...
Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced the successful close of its Series C financing round at an increased ...
More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results